158.845 de modificări
ATRECA INC TECH CODE (modificare)
Versiunea de la data 18 septembrie 2024 15:41
, 18 septembrie 2024Pagină nouă: Pagina dedicata companiei ATRECA INC TECH CODE listata cu simbolul US.BCEL ==Descriere companie== Atreca, Inc. (www.atreca.com) is a clinical-stage biopharmaceutical company. The Company use its platform to discover and develop antibody-based immunotherapeutic to treat a range of solid tumor types. The Company's lead product candidate, ATRC-101, is a monoclonal antibody with a mechanism of action and target derived from an antibody identified using its discovery platform. It...
Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei ATRECA INC TECH CODE listata cu simbolul US.BCEL ==Descriere companie== Atreca, Inc. (www.atreca.com) is a clinical-stage biopharmaceutical company. The Company use its platform to discover and develop antibody-based immunotherapeutic to treat a range of solid tumor types. The Company's lead product candidate, ATRC-101, is a monoclonal antibody with a mechanism of action and target derived from an antibody identified using its discovery platform. It...) |
(Nicio diferență)
|